First Trust NYSE Arca Biotechnology Index Fund (FBT) saw an approximate $441.5M weekly inflow, representing a 16.0% increase in shares outstanding. The flow suggests moderately positive investor sentiment toward biotech exposure, though it is unlikely to be broadly market-moving.
First Trust NYSE Arca Biotechnology Index Fund (FBT) saw an approximate $441.5M weekly inflow, representing a 16.0% increase in shares outstanding. The flow suggests moderately positive investor sentiment toward biotech exposure, though it is unlikely to be broadly market-moving.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
